GSKMEX:GSKN 73 Forward Dividend Yield % is 3.55% as of Jun. 24, 2026. GuruFocus rates MEX:GSKN with a GF Score™ of 73/100 and a GF Value™ of MXN818.82 (Fairly Valued). The stock has 1 warning sign investors should review. Among 503 Drug Manufacturers companies, GSK ranks better than 72.76% on this metric.
As of today (2026-06-24), the Forward Annual Dividend Yield of GSK is 3.55%.
As of today (2026-06-24), the Trailing Annual Dividend Yield of GSK is 3.55%.
MEX:GSKN's Forward Dividend Yield % is ranked better than 72.76% of 503
companies
in the Drug Manufacturers industry
Industry Median: 2.1
vs MEX:GSKN: 3.55
During the past 12 months, GSK's average Dividends Per Share Growth Rate was 8.20% per year.
During the past 3 years, the average Dividends Per Share Growth Rate was -5.70% per year.
During the past 5 years, the average Dividends Per Share Growth Rate was -10.90% per year.
During the past 10 years, the average Dividends Per Share Growth Rate was -5.70% per year.
During the past 13 years, the highest 3-Year average Dividends Per Share Growth Rate of GSK was 62.10% per year. The lowest was -17.70% per year. And the median was 4.10% per year.
The growth rate is calculated with least square regression.
For more information regarding to dividend, please check our Dividend Page.
Over the long term, the return from dividends has been a significant contributor to the total returns produced by equity securities. Studies by Elroy Dimson, Paul Marsh, and Mike Staunton of Princeton University (2002) found that a market-oriented portfolio, which included reinvested dividends, would have generated nearly 85 times the wealth generated by the same portfolio relying solely on capital gains.
Dividends may also qualify a lower tax rate for investors.
In dividends investing, Payout Ratio and Dividend Growth Rate are the two most important variables for consideration. A lower payout ratio may indicate that the company has more room to increase its dividends.
MEX:GSKN vs LLY, JNJ, ABBV: Forward Dividend Yield % Comparison
For the Drug Manufacturers - General subindustry, GSK's Forward Dividend Yield %, along with its competitors' market caps and Forward Dividend Yield % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
GSK Forward Dividend Yield % vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, GSK's Forward Dividend Yield % distribution charts can be found below:
* The bar in red indicates where GSK's Forward Dividend Yield % falls into.
Dividend Yield measures how much a company pays out in dividends each year relative to its share price.
GSK Recent Full-Year* Dividend History
Amount
Ex-date
Record Date
Pay Date
Type
Frequency
Forex Rate
USD 0.461074
2026-05-15
2026-05-15
2026-07-09
Cash Dividend
quarterly
USD:MXN 17.360000
USD 0.477611
2026-02-20
2026-02-20
2026-04-09
Cash Dividend
quarterly
USD:MXN 17.228000
USD 0.433113
2025-11-14
2025-11-14
2026-01-08
Cash Dividend
quarterly
USD:MXN 18.419300
USD 0.429960
2025-08-15
2025-08-15
2025-10-09
Cash Dividend
quarterly
USD:MXN 18.706300
* GuruFocus has an internal rule that if the most recent dividend payment frequency is at least 4 times a year, then the full year will be calculated according to the frequency of payment or the one-year time frame, whichever is stricter.
* GuruFocus converts dividend currency to local traded share price currency in order to calculate dividend yield. Please refer to the last column "Forex Rate" in the above table.
GSK's Forward Annual Dividend Yield (%) for Today is calculated as
Forward Annual Dividend Yield
=
Forward Full Year Dividend
/
Current Share Price
=
32.01697856
/
901.11
=
3.55 %
Current Share Price is MXN901.11. GSK's Dividends per Share for the forward twelve months is calculated as MXN8.00424464 * 4 = MXN32.01697856.
GSK's Trailing Annual Dividend Yield (%) for Today is calculated as
Trailing Annual Dividend Yield
=
Most Recent Full Year Dividend
/
Current Share Price
=
32.2531259769
/
901.11
=
3.58 %
Current Share Price is MXN901.11. GSK's Dividends per Share for the trailing twelve months (TTM) ended in Today is MXN32.2531259769.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
What does a Forward Dividend Yield % of 3.55% mean?
GSK (MEX:GSKN) has a Forward Dividend Yield % of 3.55% as of Jun. 24, 2026. Forward dividend yield is the ratio of company's expected dividends to the share price. View historical data on GSK and its competitors. According to the industry distribution chart, GSK ranks #137 out of 503 companies in the Drug Manufacturers industry, placing it in the top 27.2%.
Is GSK's Forward Dividend Yield % too high?
GSK's current Forward Dividend Yield % is 3.55%. The Drug Manufacturers industry median Forward Dividend Yield % is 2.10. GSK's value of 3.55% is 69% above this industry median. Based on the distribution chart, GSK ranks #137 out of 503 companies in the Drug Manufacturers industry, which is above the industry midpoint. Overall, GSK has a GF Score™ of 73/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does GSK's Forward Dividend Yield % compare to LLY and JNJ?
According to the Drug Manufacturers industry distribution chart, GSK ranks #137 out of 503 companies for Forward Dividend Yield %. This puts GSK in the upper half of its industry. The industry median Forward Dividend Yield % is 2.10. GSK's value of 3.55% is 69% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Forward Dividend Yield % for a Drug Manufacturers company?
The median Forward Dividend Yield % among Drug Manufacturers companies is 2.10, based on 503 companies in the industry. Companies in the top quartile (top 25%) have a Forward Dividend Yield % significantly above this median, while those in the bottom quartile fall well below. However, Forward Dividend Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. GSK's current Forward Dividend Yield % of 3.55% is 69% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Forward Dividend Yield % mean?
A high Forward Dividend Yield % can signal that a stock is expensive relative to its fundamentals. Forward dividend yield is the ratio of company's expected dividends to the share price. View historical data on GSK and its competitors. For the Drug Manufacturers industry, the median Forward Dividend Yield % is 2.10 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. GSK's current Forward Dividend Yield % is 3.55%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is GSK stock overvalued right now?
Based on GuruFocus' analysis, GSK (MEX:GSKN) is currently considered Fairly Valued. The stock's GF Value™ is MXN818.82, compared to a current price of MXN901.11 — trading 10% above its estimated fair value. The current Forward Dividend Yield % is 3.55% and 69% above the Drug Manufacturers industry median of 2.10. GSK's overall GF Score™ is 73/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Forward Dividend Yield % calculated?
Forward Dividend Yield % is calculated from a company's financial statements. For GSK (MEX:GSKN), the current Forward Dividend Yield % is 3.55% as of Jun. 24, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is GSK (MEX:GSKN) Overvalued in 2026?
Based on GuruFocus' analysis, GSK stock appears to be overvalued.
The current stock price of MXN901.11 is trading 10% above its estimated GF Value™ of MXN818.82.
GuruFocus considers GSK to be Fairly Valued.
Key valuation signals for MEX:GSKN:
Forward Dividend Yield %: 3.55%
GF Value™: MXN818.82 vs. price of MXN901.11 (10% above fair value)
Industry Position: 69% above the Drug Manufacturers median (#137 of 503)
No single metric tells the full story. See the MEX:GSKN stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
In the pharmaceutical industry, GSK ranks as one of the largest firms by total sales. The company wields its might across several therapeutic classes, including respiratory, antiviral, and vaccines, and has been growing its presence in oncology and immunology, as well. GSK uses joint ventures to gain additional scale in certain markets like HIV.
73GF Score
Get the complete analysis for MEX:GSKN
Forward Dividend Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
MEX:GSKN has been successfully added to your 